Organogenesis Inc.

NASDAQ: ORGO · Real-Time Price · USD
4.71
0.01 (0.21%)
At close: Aug 15, 2025, 3:06 PM

Organogenesis Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
135.57M 104.34M 102.48M 113.93M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 15.87M n/a n/a
Other Long-Term Assets
5M -9.88M 1.52M 1.54M
Receivables
109.86M 82M 89.45M 82.46M
Inventory
26.22M 28.25M 24.78M 25.02M
Other Current Assets
5.67M 1.19M 5.1M 711K
Total Current Assets
285.94M 225.04M 222.61M 226.98M
Property-Plant & Equipment
126.24M 156.35M 145.66M 128.3M
Goodwill & Intangibles
41.24M 44.64M 49.56M 54.45M
Total Long-Term Assets
211.94M 234.98M 226.75M 216.28M
Total Assets
497.89M 460.02M 449.36M 443.26M
Account Payables
28.91M 30.72M 32.33M 29.34M
Deferred Revenue
n/a n/a n/a 35.72M
Short-Term Debt
9.11M 5.49M 4.54M 2.66M
Other Current Liabilities
2.22M 22.17M 9.33M -5.12M
Total Current Liabilities
77.48M 80.51M 75.02M 82.7M
Long-Term Debt
34.2M 60.74M 66.23M 70.77M
Other Long-Term Liabilities
894K 1.21M 1.12M 1.56M
Total Long-Term Liabilities
35.09M 100.85M 108.67M 119.22M
Total Liabilities
112.57M 181.36M 183.69M 201.22M
Total Debt
43.31M 119.35M 123.79M 132.3M
Common Stock
13K 13K 13K 13K
Retained Earnings
-40.11M -40.97M -45.3M -60.13M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
385.32M 278.66M 265.67M 242.03M
Total Investments
n/a n/a n/a n/a